Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Edwards Lifesciences, Medtronic and Inari Medical used
Michelle Tarver, the new leader of the Food and Drug Administration’s medical device center, faces significant challenges ahead. Tarver is taking over as director of
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Boston Scientific’s Acurate Neo2 transcatheter
Britain’s hardships during World War II famously included weeks of bombing during the Blitz, the mass evacuation of children, and food rationing. That rationing, researchers
Two generic drugmakers, Apotex and Heritage Pharmaceuticals, have agreed to pay a combined $49 million to settle allegations they fixed prices on numerous medicines, the
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in
Toronto, Ontario–(Newsfile Corp. – October 31, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc. (“Psyence Group“) (CSE: PSYG) today announced the successful closing of its previously announced disposal
10/31/2024 – 07:30 AM TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty
Matinas BioPharma first reported in August that it had signed a non-binding term sheet for global licensing rights to MAT2203 for all future treatment indications.